NIH recently updated its Research, Condition, and Disease Classification (RCDC) system with FY 2020 actual spending data and estimates for FY 2021 and 2022. “Coronaviruses” is a new category as part of this update.
How will study sections meet in the future? NIH peer review depends on robust meetings where groups of scientists, through vigorous discussion, identify the applications of highest merit. For the last 75 years, until last March, nearly all chartered review committee meetings were held in-person. Today, in response to the pandemic, 90% of all CSR review meetings are run as video (“Zoom”) meetings. CSR is taking steps now so that when all options are back on the table, we can make informed choices about how best to convene review meetings.
Encouraging Participation in Upcoming NIH Surveys to Identify Impacts of COVID-19 on Extramural Research
NIH has been working diligently to support the extramural research community since the pandemic began in March. We are now preparing to reach out with surveys to gather data on how COVID-19 is impacting our extramural researchers and their institutions. If you receive such a survey, we hope that you will take the time to provide us with your perspective. The results of the surveys will be extremely valuable to inform policy and program decisions as NIH seeks to identify ways to continue to support the biomedical research enterprise as we move forward.
Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During COVID-19 Pandemic
Due to disruptions caused by the COVID-19 pandemic, NIH will be providing up to a two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of a K99/R00 application from the June/July 2020 due dates through the February/March 2021 due dates. For more details, see the full Guide … Continue reading “Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During COVID-19 Pandemic”
We continue to add new resources to our COVID-19: Information for NIH Applicants and Recipients of NIH Funding webpage. We hope they are helpful in navigating this unprecedented situation. Here is a summary of what’s new since the last Nexus.
It has been four months since the COVID-19 pandemic shuttered laboratories and clinical studies across the country and the world. On April 10, only a few weeks into the pandemic, the Congressional Research Service (CRS) published a report describing the consequences of social distancing and other pandemic mitigation measures. These consequences included laboratory closures, de-prioritized projects, cancellation of meetings and conferences, loss of revenue, disrupted personnel processes, supply-chain interruptions, and, overlying all of these, a great deal of uncertainty. Since the CRS report was issued, we have learned more about the pandemic’s effects on non-COVID research and on the research workforce.
All COVID-19 FAQs were reviewed and revised to align with NIH Implementation of OMB Memorandum M-20-26.
As we continue to address the effects of the COVID-19 public health emergency on NIH-supported research, we are aware of applicant concerns about the potential impact of this temporary emergency situation on the outcome of peer review. We want to reassure applicants that we released guidance for reviewers that makes it clear that, when reviewing applications during the coronavirus pandemic national emergency, reviewers should assume that issues resulting from the coronavirus pandemic, such as the following, should not affect scores.
What happens if an institution has already submitted an application, and due to effects of COVID-19, some of the information needs to be revised?
Institutions affected by COVID-19 will be allowed to submit post-submission grant application materials to revise information that was submitted in an application as long as the materials are received at least fourteen days before the start of the review meeting. The post-submission grant application materials policy remains in effect. Only the types of materials allowed under the policy can be accepted. A letter of explanation (one page max.) is required.
The current outbreak of the novel coronavirus (COVID-19) has introduced new cybersecurity risks both at NIH and across the globe. As targeted phishing attacks prey on our desire to access trustworthy information and many of us make a shift toward remote work, we all need to be vigilant and take accountability for cyber safety. Here are some key tips to stay safe and avoid scams.